F. Mayer
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
-
- Cancer Treatment and Pharmacology
Papers in
-
- Ovarian cancer diagnosis and treatment 9
- Oncology 3
- Cancer Treatment and Pharmacology 2
- HER2/EGFR in Cancer Research 1
- Co-authors
- Hugues Pierre Bourgeois (3 shared papers)Beatrice E. Weber (2 shared papers)Désiré Paraiso (2 shared papers)Hubert Orfeuvre (2 shared papers)Martin Combe (2 shared papers)Éric Pujade-Lauraine (2 shared papers)Pierre Kerbrat (4 shared papers)C. Lhommé (4 shared papers)
- Journals
- Annals of Oncology (4 papers)Anti-Cancer Drugs (3 papers)Gynecologic Oncology (2 papers)Cancer Research (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
F. Mayer
23 papers receiving 404 citations
Peers
Comparison fields: 5 of 32
- Reproductive Medicine 190
- Oncology 54
- Obstetrics and Gynecology 11
- Pulmonary and Respiratory Medicine 26
- Pharmacology 6
Countries citing papers authored by F. Mayer
This map shows the geographic impact of F. Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Mayer more than expected).
Fields of papers citing papers by F. Mayer
This network shows the impact of papers produced by F. Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Mayer. The network helps show where F. Mayer may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Mayer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 91 | |
| 2 | 2007 | 76 | |
| 3 | 2016 | 76 | |
| 4 | 2012 | 33 | |
| 5 | 1999 | 21 | |
| 6 | 2000 | 21 | |
| 7 | Pegylated liposomal doxorubicin and carboplatin in late-relapsing ovarian cancer: a GINECO group phase II trial. | 2009 | 19 |
| 8 | 2009 | 15 | |
| 9 | 1994 | 14 | |
| 10 | 2006 | 14 | |
| 11 | 2010 | 11 | |
| 12 | 2007 | 6 | |
| 13 | 2009 | 6 | |
| 14 | 2012 | 6 | |
| 15 | 1993 | 4 | |
| 16 | [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide]. | 1993 | 4 |
| 17 | 2016 | 4 | |
| 18 | 2012 | 3 | |
| 19 | 1995 | 2 | |
| 20 | [Targeting ErbB receptors in breast cancer]. | 2007 | 2 |
About F. Mayer
F. Mayer is a scholar working on Reproductive Medicine, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Obstetrics and Gynecology, having authored 23 papers that have together received 431 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (9 papers), Lung Cancer Diagnosis and Treatment (2 papers), Cancer Treatment and Pharmacology (2 papers), Breast Cancer Treatment Studies (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Endometrial and Cervical Cancer Treatments (1 paper), Intraperitoneal and Appendiceal Malignancies (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Reproductive Medicine (190 citations), Oncology (54 citations), Obstetrics and Gynecology (11 citations), Pulmonary and Respiratory Medicine (26 citations) and Pharmacology (6 citations). F. Mayer has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Hugues Pierre Bourgeois, Beatrice E. Weber, Désiré Paraiso, Hubert Orfeuvre, Martin Combe, Éric Pujade-Lauraine, Pierre Kerbrat, C. Lhommé, J.-F. Geay and Jean-Marc Ferrero. Their work appears in journals such as Annals of Oncology, Anti-Cancer Drugs, Gynecologic Oncology, Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.